Search
Alpibectir
go.drugbank.com/drugs/DB21561InvestigationalAlpibectir is under investigation in clinical trial NCT06748937 (A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide).
Ceperognastat
go.drugbank.com/drugs/DB21591InvestigationalCeperognastat is under investigation in clinical trial NCT05063539 (A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease).
Ranosidenib
go.drugbank.com/drugs/DB21727InvestigationalRanosidenib is under investigation in clinical trial NCT06387069 (A Study to Evaluate HMPL-306 in Patients With IDH1- and IDH2-mutated Acute Myeloid Leukemia).
IL21120033
go.drugbank.com/drugs/DB32508ExperimentalIL21120033 is a first-in-class, small-molecule selective CXCR7 agonist.
Roluperidone
go.drugbank.com/drugs/DB13080InvestigationalRoluperidone has been used in trials studying the treatment of Schizophrenia.
α-Methylfentanyl
go.drugbank.com/drugs/DB01557ExperimentalIllicitα-Methylfentanyl is an analog of fentanyl with opioid analgesic properties.
D-Leucine
go.drugbank.com/drugs/DB01746ExperimentalAn essential branched-chain amino acid important for hemoglobin formation. [PubChem]
Danusertib
go.drugbank.com/drugs/DB11778InvestigationalDanusertib has been used in trials studying the treatment of Leukemia.
Famzeretcel
go.drugbank.com/drugs/DB17906InvestigationaljCell is an human retinal progenitor cell therapy for retinitis pigmentosa.
XPro1595
go.drugbank.com/drugs/DB16454InvestigationalXPro1595 is an investigational dominant-negative protein that neutralizes soluble TNF.
Synonyms: HOMOSAPIENS TUMOR NECROSIS FACTOR,SOLUBLE FORM (V1>M, R31>C, C69>V, Y87>H, C101>A, A145>R), MONOMER, PEGYLATED ON CYSTEINE 31 : S-((3RS)-(2-((3-(.OMEGA.